Hemp, botanically Cannabis sativa, was domesticated in East Asia as early as the Neolithic period, several thousand years ago, before spreading to Europe and the rest of the world. CBD, or cannabidiol, is a molecule naturally present in this same plant: it is formed from CBDA under the influence of heat or time. Today, European regulations strictly govern its production and sale, notably through its novel food status and specific THC thresholds.
In short:
- The CBD content declared on a product does not guarantee a compliant THC level; you should always check the certificate of analysis to avoid any legal exceedance.
- CBD is formed from the precursor CBDA, which is transformed by decarboxylation under the effect of heat or time, and does not exist naturally in this active form in the plant.
- The extraction method influences the quality of the final product, with supercritical CO₂ extraction offering the profile most faithful to the original plant.
- The marketing of CBD in Europe requires scientific evaluation and authorization from the European Commission if the product is extracted in concentrated form, in accordance with the novel food status.
Table of Contents
- Historical and archaeobotanical origins of hemp: where and when?
- Botany and genetics: how varieties became specialized
- Chemical origin of CBD and common extraction methods
- European and French legal framework: Novel Food, THC thresholds and recent developments
- From the traditional plant to the modern CBD market
- What the studies show: established indications and limitations
- Traceability, laboratory analyses and reader verification
- History of the traditional use of hemp across cultures
- Environmental impact and ecological benefits of hemp cultivation
- Industrial and medicinal applications, from yesterday to today
- Editorial perspective: why knowing your origins helps you choose
- Where to find traceable CBD flowers and resins
- Sources
- Frequently Asked Questions
Historical and archaeobotanical origins of hemp: where and when?
The most recent genomic analyses place the cradle of hemp domestication in East Asia, with a divergence between wild and cultivated populations dating back approximately 12,000 years, according to domestication Cannabis sativa. Current cultivars, whether intended for fiber or psychoactive use, derive from the same ancestral pool represented by ancient Chinese landraces.
Archaeological evidence corroborates this genomic chronology through several types of remains:
- Imprints of woven fibers and ropes found at Neolithic sites in China and Japan.
- Charred seeds associated with ancient food practices.
- Dated pollen grains confirming the presence of the plant well before its use was documented in writing.
- Pottery and ceramics marked by hemp fabric imprints, used as indirect dating indicators.
The Tibetan Plateau and the bordering regions of present-day China appear as pivotal areas in this spread, the plant subsequently migrating to Central Asia and then Europe via ancient trade routes. From this period onward, three uses coexisted: textile fiber, food (via the seeds), and a ritual or medicinal use, the extent of which remains difficult to quantify precisely.
Botany and genetics: how varieties became specialized
Cannabis sativa remains, in the botanical sense, a unique species.
This divergence is explained at the molecular level by two key genes:
- THCAS, the synthase that produces THCA, the precursor of THC.
- CBDAS, the synthase responsible for CBDA, the precursor of CBD.
Sequencing studies published in Science Advances show that selection has led to loss of function or variations in the expression of these two synthases, depending on the intended use. This explains why some lines produce almost exclusively CBDA, while others favor THCA, according to genomic analyses of cannabis domestication. This genetic specialization directly influences the final cannabinoid content of a given cultivar, a point explored in more detail in our article on the differences between hemp, cannabis, CBD, and THC.
Pro tip: A high CBD content on a product page tells you nothing about the associated THC content. Always check both values on the certificate of analysis, not just the one highlighted in the marketing materials.
Chemical origin of CBD and common extraction methods
CBD does not exist in this active form in the living plant. It comes from an acidic precursor, CBDA, which is transformed by decarboxylation, a process triggered by heat, light or simply the aging of plant matter, as recalled in the WHO technical summary on cannabidiol.
On the market, three main families of processes allow for obtaining an extract from the flower or resin:
- Supercritical CO₂ extraction, which limits solvent residues and preserves a cannabinoid profile close to the original plant.
- Solvent extraction (especially ethanol) is faster but requires rigorous purification.
- Infusion in a carrier oil, a more artisanal method, often used for consumer CBD oils, and detailed in our guide on CBDA and its transformation into CBD.
The chosen method directly influences the final result: an isolate contains only purified CBD, free of other compounds, while a full-spectrum extract retains terpenes and secondary cannabinoids, with the nuances of effect that this implies.
European and French legal framework: Novel Food, THC thresholds and recent developments
In Europe, CBD falls under the category of novel food as soon as it is extracted in concentrated form: this means that no product containing a CBD extract can be legally marketed without prior authorization from the European Commission, based on a scientific assessment by the EFSA (European Food Safety Authority). This status stems from the lack of significant consumption history before 1997, as specified in the European Commission's statement on CBD and novel food.
Key figure: the European regulation sets maximum levels of Δ9-THC depending on the product, with a specific conversion factor to transform Δ9-THCA into Δ9-THC equivalent, according to the annex to regulation (EU) 2026/1828.
In practice, these limits vary greatly depending on the commodity:
- Maximum levels set at a few mg/kg for whole hemp seeds.
- Maximum levels set at several mg/kg for the oil derived from these seeds.
- Lower thresholds for hemp-based infusions and herbal teas.
This framework also relies on Regulation (EU) 2022/1393, which introduced an acute reference dose (ARfD) of 1 µg per kilogram of body weight established by the EFSA. For producers and sellers, these rules require strict traceability of each batch; for consumers, they explain why two products with a similar appearance can have different legal statuses. Our page dedicated to the regulatory framework for CBD in France and Europe details these thresholds product by product.
From the traditional plant to the modern CBD market
Cannabidiol was chemically isolated in the 20th century, but its large-scale commercial exploitation remains a recent phenomenon, largely subsequent to its discovery in the laboratory. For decades, the molecule remained a research curiosity rather than a consumer product.
What changed the market was not a major new scientific discovery, but a growing demand for non-psychoactive alternatives perceived as natural:
- Seeking solutions for relaxation and stress management in daily life.
- Interest in sleep routines without systematic recourse to conventional sleeping pills.
- A desire to switch to plant-based products rather than synthetic ones.
This commercial momentum, however, largely preceded the consolidation of scientific evidence. Most self-medication practices, particularly for anxiety or daily pain management, are based on still limited clinical data, a point that the following section details precisely.
What the studies show: established indications and limitations
The most solidly demonstrated indication for CBD concerns certain rare forms of epilepsy, where its use falls under the category of a prescription drug and not a wellness supplement, according to the systematic review of clinical evidence on CBD.
Key figure: for anxiety and chronic pain in self-medication, the same studies consider the current evidence insufficient to establish reliable effectiveness, despite the popularity of these uses.
- Risk of interactions via cytochrome P450 enzymes, relevant for anyone undergoing drug treatment.
- Possible side effects: gastrointestinal disturbances, fatigue, changes in appetite.
Our article on CBD and chronic pain details these nuances, as does our page on the side effects of CBD compiled from reported cases.
Traceability, laboratory analyses and reader verification
Understanding the botanical and chemical origin of CBD is only truly valuable if it's accompanied by concrete verification of the purchased product. Some shops document their traceability practices and compliance with legal THC limits through independent laboratory analyses, the certificates of which can be viewed on the corresponding product pages. This approach aligns with educational materials published by sources like Ameli on non-medical CBD, which consistently recommend cross-referencing commercial information with verifiable data before making any purchase.
History of the traditional use of hemp across cultures
In ancient China, hemp was used for both weaving clothes and making paper, an application documented as early as the Han dynasty and considered one of the first recorded industrial uses of the plant. The seeds were also used in food, pressed for their oil or eaten whole.
In Japan, hemp fiber has long held a ritual place, used in certain Shinto clothing and sacred ropes, a tradition that continues symbolically today in some shrines.
On the Indian subcontinent, the plant followed a different trajectory: preparations based on leaves and resin occupied a place in certain ancient religious and medicinal practices, distinct from the fibrous use favoured in the Far East.
In North Africa and the Middle East, resin-based preparations circulated along trade routes as early as Late Antiquity, long before modern chemistry made it possible to isolate the molecules responsible for their effects. This diversity of traditional uses, far from being anecdotal, shows that hemp has always been a plant with multiple purposes rather than a crop with a single objective.
Environmental impact and ecological benefits of hemp cultivation
Hemp has several agronomic characteristics that explain the renewed interest it is generating in a logic of more resource-efficient production.
The plant generally requires fewer plant protection products than other fibrous crops, due to its rapid and dense growth which naturally limits weed development. Its deep root system also helps to structure the soil, an advantage for crop rotations on depleted plots.
In terms of water consumption, hemp often proves less water-intensive than cotton over a comparable growing cycle, a factor regularly highlighted by textile industries seeking less irrigation-intensive alternatives. The plant also absorbs a significant amount of carbon dioxide during its rapid growth, making it a crop being studied in some agricultural carbon sequestration projects.
Every part of the plant finds a use: the fiber for textiles or building materials, the hurd for insulation, the seed for edible oil, and the flower for cannabinoid extraction. This comprehensive utilization limits agricultural waste compared to crops where only a fraction of the plant is commercially exploited. However, these agronomic qualities do not negate the need for strict regulations on cultivated varieties, particularly regarding their permitted THC content.
Industrial and medicinal applications, from yesterday to today
Historically, hemp was first an industrial raw material before becoming a source of isolated cannabinoids. Naval ropes, sailcloth, paper, and later certain technical textiles constituted the bulk of its exploitation for centuries, in both Europe and Asia.
The modern era has added new applications to this long-standing list: hemp fiber-reinforced bioplastics, hempcrete for building insulation, and cosmetics incorporating seed oil for its emollient properties. In the medicinal field, the traditional use of hemp preparations dates back to ancient texts in China and India, but these empirical uses do not meet the standards of evidence required by modern medicine.
Today, only a limited number of medicinal applications of CBD have solid clinical validation, primarily for certain forms of drug-resistant epilepsy treated with a specific prescription medication. Other uses, whether dietary supplements or over-the-counter wellness products, fall into a different category: that of non-therapeutic use governed by food regulations rather than pharmaceutical law. This distinction between long-standing industrial practices and contemporary regulated uses is worth keeping in mind when faced with marketing claims that are sometimes overly optimistic.
Editorial perspective: why knowing your origins helps you choose
Knowing the botanical origin of hemp is never a substitute for a current certificate of analysis. The key is to separate the plant's history from commercial claims, and to consult a doctor if you are currently undergoing treatment.
— Vanessa
Where to find traceable CBD flowers and resins
Understanding where hemp comes from is one thing; ensuring that a given product actually meets legal thresholds is another, and that's where concrete verification becomes essential.
Thefrenchhempempire builds its catalog around this same requirement for traceability: each reference of CBD flowers or CBD resins comes with a verified origin and independent laboratory analysis, available for consultation before any purchase. Readers interested in more discreet formats can also browse the CBD vapes or CBD small buds, a range designed for occasional use. Before placing any order, simply take the time to verify the certificate of analysis associated with each product and ensure that it corresponds to the THC level stated on the product page.
Sources
- Whole-genome analyzes provide insights into the domestication history of Cannabis sativa
- Regulation (EU) 2026/1828 (Annex on maximum levels of Δ9-THC)
- WHO review on cannabidiol (technical summary)
This article provides general information and is not a substitute for professional medical advice. Consult a qualified healthcare professional about your specific situation before taking any action based on this content.
Frequently Asked Questions
What is the origin of hemp?
Hemp was domesticated in East Asia during the Neolithic period, with converging archaeological and genomic evidence placing this process in China several thousand years ago, according to genomic analyses of its domestication. It then spread to Central Asia and subsequently to Europe via ancient trade routes.
Where does CBD come from?
CBD comes directly from the hemp plant, where it is formed from an acidic precursor, CBDA, which is transformed by decarboxylation under the influence of heat or time. It is therefore not a synthetic molecule but a natural compound extracted through various processes, as outlined in the WHO summary on cannabidiol.
What is the difference between CBD and hemp?
Hemp is the entire plant, cultivated for its fiber, seeds, and flowers. CBD is a specific molecule extracted from this plant, distinct from THC, and its use is governed by regulations specific to concentrated extracts rather than the raw plant.
Can CBD help with sciatica?
Robust clinical evidence on CBD primarily concerns certain forms of epilepsy, and not nerve pain such as sciatica, where data remains limited according to the systematic review of clinical evidence. Any persistent pain of this type warrants medical advice rather than self-medication, especially since drug interactions are possible.
Is CBD legal everywhere in Europe?
CBD falls under the category of novel food in the European Union, which requires prior authorization for concentrated extracts, and specific Δ9-THC thresholds govern each product category according to the European regulation on maximum THC levels. However, the precise rules may vary from one Member State to another for certain sales formats.
